1. Home
  2. GENC vs DRUG Comparison

GENC vs DRUG Comparison

Compare GENC & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

N/A

Current Price

$17.50

Market Cap

254.2M

Sector

Industrials

ML Signal

N/A

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

N/A

Current Price

$22.74

Market Cap

228.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GENC
DRUG
Founded
N/A
2019
Country
United States
United States
Employees
N/A
25
Industry
Construction/Ag Equipment/Trucks
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.2M
228.0M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
GENC
DRUG
Price
$17.50
$22.74
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
$21.00
★ $107.21
AVG Volume (30 Days)
32.5K
★ 255.8K
Earning Date
12-08-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.08
N/A
EPS
★ 0.89
N/A
Revenue
★ $48,943,000.00
N/A
Revenue This Year
$1.78
N/A
Revenue Next Year
$25.68
N/A
P/E Ratio
$19.90
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$12.22
$17.40
52 Week High
$20.19
$123.75

Technical Indicators

Market Signals
Indicator
GENC
DRUG
Relative Strength Index (RSI) 52.07 27.92
Support Level $16.75 $17.40
Resistance Level $18.11 $58.93
Average True Range (ATR) 0.55 3.55
MACD 0.05 -1.19
Stochastic Oscillator 70.15 13.22

Price Performance

Historical Comparison
GENC
DRUG

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: